PH21734A - Pinacidil containing pharmaceutical preparations in slow release form - Google Patents

Pinacidil containing pharmaceutical preparations in slow release form

Info

Publication number
PH21734A
PH21734A PH30189A PH30189A PH21734A PH 21734 A PH21734 A PH 21734A PH 30189 A PH30189 A PH 30189A PH 30189 A PH30189 A PH 30189A PH 21734 A PH21734 A PH 21734A
Authority
PH
Philippines
Prior art keywords
pinacidil
pharmaceutical preparations
slow release
release form
containing pharmaceutical
Prior art date
Application number
PH30189A
Other languages
English (en)
Inventor
Erik Johannes Didriksen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PH21734A publication Critical patent/PH21734A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PH30189A 1983-02-11 1984-02-02 Pinacidil containing pharmaceutical preparations in slow release form PH21734A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
PH21734A true PH21734A (en) 1988-02-10

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30189A PH21734A (en) 1983-02-11 1984-02-02 Pinacidil containing pharmaceutical preparations in slow release form

Country Status (15)

Country Link
US (1) US4600577A (ko)
JP (1) JPS59155312A (ko)
BE (1) BE898882A (ko)
DE (1) DE3404595A1 (ko)
DK (1) DK58983D0 (ko)
ES (1) ES8608490A1 (ko)
FR (1) FR2540727B1 (ko)
GB (1) GB2134785B (ko)
IE (1) IE56604B1 (ko)
IT (1) IT1196682B (ko)
NL (1) NL8400430A (ko)
NZ (1) NZ207010A (ko)
PH (1) PH21734A (ko)
SE (1) SE447871B (ko)
ZA (1) ZA84856B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE3887591T2 (de) * 1987-07-07 1994-05-19 Beecham Group Plc Pinacidil zur Behandlung von pulmonaler Hypertonie oder Rechtsversagen.
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
ES2197600T3 (es) 1999-01-29 2004-01-01 Disphar International B.V. Composiciones farmaceuticas.
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
IL151150A0 (en) * 2001-01-31 2003-04-10 Roehm Gmbh Multiparticulate drug form comprising at least two differently coated pellet forms
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
US8173158B2 (en) 2007-10-12 2012-05-08 Takeda Pharmaceuticals U.S.A., Inc. Methods of treating gastrointestinal disorders independent of the intake of food

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
IT1196682B (it) 1988-11-25
ES8608490A1 (es) 1986-06-16
ZA84856B (en) 1984-09-26
IT8467131A0 (it) 1984-02-13
FR2540727A1 (fr) 1984-08-17
GB8403572D0 (en) 1984-03-14
FR2540727B1 (fr) 1987-01-23
SE447871B (sv) 1986-12-22
IE56604B1 (en) 1991-10-09
DK58983D0 (da) 1983-02-11
JPS59155312A (ja) 1984-09-04
GB2134785B (en) 1986-07-02
GB2134785A (en) 1984-08-22
DE3404595C2 (ko) 1993-04-29
US4600577A (en) 1986-07-15
IE840146L (en) 1984-08-11
JPH0451528B2 (ko) 1992-08-19
NL8400430A (nl) 1984-09-03
SE8400723L (sv) 1984-08-12
NZ207010A (en) 1987-06-30
BE898882A (fr) 1984-08-10
DE3404595A1 (de) 1984-08-16
ES529660A0 (es) 1986-06-16
SE8400723D0 (sv) 1984-02-10

Similar Documents

Publication Publication Date Title
GR80788B (en) Drug preparations
GB8421946D0 (en) Cosmetic/pharmaceutical composition
GB8414688D0 (en) Pharmaceutical preparation
PH21734A (en) Pinacidil containing pharmaceutical preparations in slow release form
GB8306264D0 (en) Pharmaceutical preparations
ZA846991B (en) Biopolymer formulations and processes for preparing them
DE3466389D1 (en) Novel pharmaceutical compounds and their preparation
ZA847825B (en) Caphalosporin derivatives and processes for their preparations
GB8306473D0 (en) Analgesic preparations
GB8410363D0 (en) Pharmaceutical preparation
GB8419863D0 (en) Pharmaceutical preparations
DE3466477D1 (en) Pharmaceutical formulations
GB8405675D0 (en) Analgesic preparations
GB8422453D0 (en) Pharmaceutical formulation
GB2142334B (en) Immunogenic preparations
GB8329238D0 (en) Pharmaceutical preparations
GB8328713D0 (en) Pharmaceutical preparations
GB8415453D0 (en) Pharmaceutical preparations
ZA847975B (en) Beta-elemonic acid and pharmaceutical preparations
GB8412342D0 (en) Pharmaceutical preparations
GB8520307D0 (en) Antiacidotic medicinal agent
GB8332451D0 (en) Pharmaceutical formulations
GB8316497D0 (en) Pharmaceutical formulations
GB8316498D0 (en) Pharmaceutical formulations
GB8316496D0 (en) Pharmaceutical formulations